← Open Payments lookup

MEGAN HIGH: Open Payments

NPI 1326627175 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$388 in 18 payments from 10 companies in 2025. Trend: 2023 $1,517 · 2024 $2,395 · 2025 $388

Food & beverage: $388
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$104
ABBVIE INC.2$49
E.R. Squibb & Sons, L.L.C.3$49
Axsome Therapeutics, Inc.2$37
Otsuka America Pharmaceutical, Inc.2$33
Vanda Pharmaceuticals Inc.1$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Teva Pharmaceuticals USA, Inc.1$22
Janssen Pharmaceuticals, Inc1$19
Lundbeck LLC1$15

Products named: INGREZZA, VRAYLAR, COBENFY, REXULTI, Auvelity, FANAPT, CAPLYTA, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.